©The Author(s) 2024.
World J Gastroenterol. Feb 21, 2024; 30(7): 759-769
Published online Feb 21, 2024. doi: 10.3748/wjg.v30.i7.759
Published online Feb 21, 2024. doi: 10.3748/wjg.v30.i7.759
Figure 1 PRISMA 2020 flow diagram.
Selection of studies to review the diagnostic and prognostic value of type 2 diabetes mellitus and metformin for predicting the insurgence and post-treatment outcome of pancreatic neuroendocrine tumor.
- Citation: Cigrovski Berkovic M, Coppola A, Sesa V, Mrzljak A, Lai Q. Metformin and pancreatic neuroendocrine tumors: A systematic review and meta-analysis. World J Gastroenterol 2024; 30(7): 759-769
- URL: https://www.wjgnet.com/1007-9327/full/v30/i7/759.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i7.759